Access cutting-edge ovarian cancer treatment through this clinical trial at a research site in Omaha. Study-provided care at no cost to qualified participants.
Access ovarian cancer specialists in Omaha at no cost
This study follows strict safety protocols and ethical guidelines
All study-related ovarian cancer treatment provided free
The main goals of this study are to learn about the safety of sacituzumab tirumotecan with bevacizumab and if people tolerate it; and If people who take sacituzumab tirumotecan with or without bevacizumab live longer without the cancer getting worse than those who receive standard of care treatment.
Sponsor: Merck Sharp & Dohme LLC
Check if you qualify for this ovarian cancer clinical trial in Omaha, NE
If you're searching for ovarian cancer treatment options in Omaha, NE, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Omaha research site is actively enrolling participants for this clinical trial. You'll receive care from experienced ovarian cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.